Multifaceted Determinants for Achieving Glycemic Control

Chan, Juliana C.N.; Gagliardino, Juan José; Baik, Sei Hyun; Chantelot, Jean-Marc; Ferreira, Sandra Roberta Gouvêa; Hâncu, Nicolae; İlkova, Hasan; Ramachandran, Ambady; Aschner, Pablo

doi:10.2337/dc08-0435

Cited by 256 publications

(246 citation statements)

References 17 publications

Supporting

Mentioning

212

Contrasting

Unclassified

Order By: Relevance

“…The results of a European cohort study (RECAP-DM) in 2008 showed that the overall frequency of adequate glycemic control among 2,023 T2DM patients was one quarter (25.5%) (26). In another international longitudinal study (IDMP study) among 11,799 diabetic patients, recruited from 17 developing countries in 2009, results illustrated that only 20-30% of patients achieved the goal of less than 7% for HbA1c (27). The findings of a recent multicenter, cross-sectional survey of outpatients carried out in 606 hospital in all provinces of China among more than 230 thousands T2DM demonstrated that less than one third of the patients achieved the goal of HbA1c less than 7% (28).…”

Section: Resultsmentioning

confidence: 99%

Inadequate control of diabetes and metabolic indices among diabetic patients: A population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS)

Yousefzadeh

Shokoohi

Najafipour

2014

Int J Health Policy Manag

View full text Add to dashboard Cite

Background: The goal of diabetes control should be feasible in order to minimize the risk of its adverse events and to reduce its burden and cost on patients. The current study aimed to assess the status of glycemic control in male and female patients with Type 2 Diabetes Mellitus (T2DM) in Kerman, Iran. Methods: In the present study, 500 T2DM (300 women and 200 men) from the Kerman Coronary Artery Disease Risk Study (KERCADRS), a population-based study from 2009 to 2011, were selected. Patients were >18 years old, had Fasting Blood Sugar (FBS) higher than 126 mg/dl, and had been through treatment for their diagnosed disease. All participants underwent Glycosylated Hemoglobin (HbA1c) analysis. HbA1c less than 7% was considered as good glucose control. Other metabolic indices based on American Diabetes Association (ADA) target recommendations were considered. Results: The mean level of HbA1c in total subjects was 8.56 ± 4.72% that only 31.66% of men and 26.00% of women had controlled level of HbA1c. Total cholesterol less than 200 mg/dl was reported in 64.50% of men and 44.00% of women, High Density Lipoprotein (HDL) more than 40 mg/dl was revealed in 20.50% of men and 34.67% of women, and Low Density Lipoprotein (LDL) less than 100 mg/dl was reported in 41.50% of men and 25.33% of women. In multivariate logistic regression model, longer duration of disease and higher Waist Circumference (WC) were positively associated with uncontrolled diabetes status. Conclusion:The findings of the present study revealed that diabetes control in T2DM was inadequate. Changing the policy of treatment in individual patient and establishing better diabetes clinic to decrease the frequency of uncontrolled T2DM are crucial. Paying attention to other affecting metabolic components such as WC in the process of T2DM management is important.

show abstract

Section: Resultsmentioning

confidence: 99%

Inadequate control of diabetes and metabolic indices among diabetic patients: A population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS)

Yousefzadeh

Shokoohi

Najafipour

2014

Int J Health Policy Manag

View full text Add to dashboard Cite

show abstract

“…However, the SMBG implementation is far from satisfactory worldwide. For instance, the International Diabetes Management Practices Study (IDMPS) found that the rate of SMBG use was only 29.7%, 35.7%, and 38.5% among T2DM patients in Asia, Eastern Europe, and Latin America (9). Patients' SMBG compliance is an important factor in determining the performance of SMBG.…”

Section: Original Articlementioning

confidence: 99%

Compliance to self-monitoring of blood glucose among patients with type 2 diabetes mellitus and its influential factors: a real-world cross-sectional study based on the Tencent TDF-I blood glucose monitoring platform

Hu¹,

Zhang²,

Huang³

et al. 2017

mHealth

View full text Add to dashboard Cite

Background: To investigate the compliance to self-monitoring of blood glucose (SMBG) among patients with type 2 diabetes mellitus (T2DM) and its influential factors. Methods:The real-world SMBG use over 90 days among 415 T2DM patients were recorded by using a blood glucose monitoring platform (TDF-I, Tencent, China). Clinical features including age, sex, duration of diabetes, insulin treatment or not, and use of oral antidiabetic drugs were collected. Poor compliance was defined as the average frequency of weekly SMBG use over 90 days was below the criteria established by the physicians, and otherwise the patients were regarded as with good compliance. Factors affecting the SMBG compliance were analyzed by using independent sample t-test, Mann-Whitney U test, and multivariate logistic regression analysis.Results: Only 57.6% of patients in the study cohort had good compliance to SMBG. Multivariate logistic regression models showed that only the duration of T2DM and the use of oral antidiabetic agents were independently associated with SMBG compliance; more specifically, patients with longer course of disease had poorer SMBG compliance, and those had used oral antidiabetic agents had poorer SMBG compliance.Conclusions: SMBG compliance in T2DM patients needs to be further improved. For patients with a longer course of disease and/or under oral antidiabetic medication, interventions such as patient education should be adopted to increase the SMBG compliance.Keywords: Type 2 diabetes mellitus (T2DM); self-monitoring of blood glucose (SMBG); compliance; crosssectional study; real world study 87-91% of all diagnosed cases of diabetes. Diabetes kills over 5 million people every year, and most of them died of diabetic complications (3). Some studies including the UK Prospective Diabetes Study (UKPDS) and the Diabetes Control and Complications Trial (DCCT) have confirmed that good blood sugar control could effectively reduce the risk of diabetic complications (4,5). Thus, blood glucose monitoring has become essential for evaluating diabetic patients, developing a reasonable hypoglycemic regimen, reflecting the effectiveness of hypoglycemic treatment, and guiding treatment adjustment. Self-monitoring of blood glucose (SMBG) has been recommended for all diabetic patients in guidelines released by IDF, American Diabetes Association (ADA), and many other organizations (6,7).Studies have revealed that SMBG can significantly improve metabolic control in T2DM patients and may reduce diabetes-related endpoint events (6,8). However, the SMBG implementation is far from satisfactory worldwide. For instance, the International Diabetes Management Practices Study (IDMPS) found that the rate of SMBG use was only 29.7%, 35.7%, and 38.5% among T2DM patients in Asia, Eastern Europe, and Latin America (9). Patients' SMBG compliance is an important factor in determining the performance of SMBG. Thus, it is particularly important to identify the patients' SMBG compliance and its influential factors. Although a number of previous studies have...

show abstract

“…A pesar de las recomendaciones clínicas basadas en la evidencia, hay múltiples estudios que indican que no se consigue un grado de control aceptable en una proporción importante de diabéticos (11)(12)(13)(14)(15). Así, en América Latina se han encontrado cifras muy altas, hasta de un 70% de pacientes diabéticos con control metabólico inadecuado (16)(17)(18)(19).…”

Section: Introductionunclassified